# Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

> **NCT00302536** · NA · WITHDRAWN · sponsor: **Nanjing University School of Medicine**

## Conditions studied

- Focal Glomerulosclerosis

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00302536
- **Lead sponsor:** Nanjing University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There was less patients recruited.
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302536, "Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00302536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*